Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ara h 2 is a major peanut allergen and a conglutin seed storage protein belonging to the 2S albumin family. It is one of the most potent and clinically significant allergens in peanuts, recognized by IgE antibodies in approximately 80–97% of individuals with peanut allergy. Sensitization to Ara h 2 is strongly associated with more severe allergic reactions, including anaphylaxis. It consists of five α-helices held together by four disulfide bridges, conferring high resistance against gastrointestinal enzymes and heat, allowing intact IgE-binding epitopes to persist.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peanut Allergen Ara h 2.